For Authors

Medicine, Science and Education accepts manuscripts in Kazakh, Russian, and English in population health and public health, experimental and clinical medicine, and medical education.

Manuscript requirements depend on the article type and study design.

1. Submission Conditions

All authors must approve the submission. A manuscript must not be under consideration by another journal at the same time. Authors confirm the accuracy of the information provided, the verification of data and references, and compliance with the rights governing all materials used.

Related articles, preprints, dissertations, conference abstracts, and registered protocols must be disclosed in the cover letter with permanent links. Their existence does not automatically constitute duplicate journal publication. A secondary analysis of the same sample must address a distinct research question and cite related work.

Manuscripts are submitted through the journal’s electronic system. In the event of a technical failure, materials may be sent to mse.journal@ksph.kz for subsequent entry into the system.

2. Article Types, Length, and Structure

Exceptions to the word limits may be agreed with the editor where scientifically justified. The number and selection of references should reflect the content and provide an adequate evidence base.

3. Submission Materials

The submission must include:

• an anonymized main manuscript in DOCX format;
• a separate title page and author information;
• a cover letter;
• individual confirmations and declarations from every author;
• tables, figures, and supplementary materials;
• a completed reporting-guideline checklist, where applicable;
• ethics documents, consents, and permissions appropriate to the research;
• for clinical trials, registration details, the protocol, and the statistical analysis plan, with dates and version numbers.

The cover letter must identify the manuscript title, article type, subject area, and corresponding author, and explain the importance of the research question, the main contribution, and relevance to the journal.

The title page must include the title in all three languages, article type and subject section, consistently spelled author names, affiliations, cities, countries, email addresses, and ORCID identifiers. Where an ORCID cannot reasonably be provided, a verifiable institutional profile is acceptable. The corresponding author must be identified separately. UDC and IRSTI classification codes must correspond to the article’s content.

For each author, also provide the name in the manuscript language and in Latin script, academic degree and title where applicable, position or student status, the full official names of the institution and department, and CRediT roles. The corresponding author’s telephone number is used for internal editorial communication and is not published without separate consent.

4. Formatting and Anonymization

The main manuscript must use:

• A4 page size;
• Times New Roman, 12-point font;
• 1.5 line spacing;
• margins of at least 2 cm;
• consecutive page numbering;
• editable text, tables, and equations.

Line numbering is recommended to facilitate peer review.

Remove author names, affiliations, identifying acknowledgments, identifying file properties, and other direct indications of authorship from the main manuscript. Scientifically necessary self-citations should be retained in neutral wording. Complete declarations and ethics documents must be supplied separately to the editor; the relevant information is restored to the manuscript after anonymous review.

Tables and figures must be numbered in order of citation and include self-contained titles, units of measurement, explanations of abbreviations, and necessary notes. Images must be of sufficient quality for assessment and publication, and originals must be retained. Composite images and any processing must be identified. Permissions for third-party content must be provided before acceptance.

5. Title, Abstract, and Keywords

The title, abstract, keywords, and author information must be provided in Kazakh, Russian, and English. All language versions must convey the same facts, numerical data, and conclusions. Machine translations must be checked by a competent specialist.

The title must accurately reflect the research question and design. Provide three to six keywords or established phrases in each language. MeSH terminology is recommended for medical concepts.

An original research abstract must include the objective, materials and methods, results, and conclusion. Results should report the principal numerical findings and measures of uncertainty where applicable. The abstract must not contain references, information absent from the article, or unsupported causal claims.

Review abstracts should describe the search and synthesis methods actually used. Case report abstracts should summarize the observation and its justified conclusion.

6. Research in Context and Reporting Guidelines

Original research articles and systematic reviews must include a “Research in Context” section of up to 250 words, placed after the abstract in the manuscript language, with the following components:

• “What was already known”;
• “What this study adds”;
• “Implications of the findings.”

Authors must explain the basis for assessing existing evidence, the specific contribution of the work, and justified implications for practice, policy, or further research. Systematic reviews must explain how they differ from previous reviews. This section does not replace the introduction or discussion.

The contribution must not be limited to a claim that the study is the first of its kind. Authors should explain the knowledge gap addressed, why the design answers the research question, and the circumstances in which the findings are applicable.

Use the reporting guideline appropriate to the study design:

Submit a completed checklist identifying the relevant manuscript pages. Narrative reviews must describe the literature search and selection, critical analysis, and limitations.

7. Authorship, Ethics, and Required Declarations

Each author must meet all four ICMJE authorship criteria: a substantial contribution to the research; participation in drafting or substantive revision; approval of the final version; and accountability for the accuracy and integrity of the work. Contributions must be described using CRediT roles.

Every co-author must provide an individual signed or verifiable electronic confirmation. Confirmation by the corresponding author does not replace individual confirmations or disclosures of interests.

The following statements must appear after the main text:

• author contributions;
• funding, grant details, and the sponsor’s role;
• conflicts of interest;
• ethics approval;
• consent to participate and, separately, consent for publication where applicable;
• study registration;
• availability of data and supplementary materials;
• use of generative AI;
• acknowledgments and permissions.

The absence of funding, conflicts of interest, or generative AI use must be stated explicitly. Explain why any declaration is not applicable.

Original research articles must name the authors who had direct access to and verified the underlying data. For multi-author work, at least two authors must confirm this verification; in academic–commercial collaborations, at least one must represent an academic institution. For single-author work, the author confirms verification and the editor determines the necessary extent of independent checking.

Where ethics approval is required, it must be obtained before the relevant research procedures begin. Provide the committee name, decision date, and reference number. Case reports require documented consent for publication from the patient or legal representative.

Clinical trials must be registered in a primary registry within the WHO ICTRP network or in ClinicalTrials.gov no later than the first participant’s consent to enrollment. Applicable national requirements must also be met. Include the registration number at the end of the abstract. Late registration must be disclosed and may be considered only as a justified exception at the editorial team’s discretion.

Systematic reviews must report protocol and registration details or explain their absence. Every scientific article must include a data availability statement describing restrictions and access procedures. Clinical trial statements must specify the data and documents available, access dates and duration, conditions, and access mechanism. “Undecided” is not an acceptable response.

Generative AI use must be disclosed in the cover letter and manuscript, identifying the tool, available version, purpose, stage of use, and human verification. Basic spelling checks that do not generate content do not require a separate disclosure.

8. References

Use the numbered Vancouver style. References must appear in order of first citation, with in-text citations in square brackets. Repeated citations retain their original number. References must not be divided into domestic and international sources.

Journal article references must include the authors, article title, journal name or correct abbreviation, year, volume, issue, pages or article number, and DOI where available. For articles with more than six authors, list the first six followed by et al. Web references must include the URL and access date. Each reference must be checked against the original source.

Where sources are written in Cyrillic or another non-Latin script, provide an additional References section in Latin script with identical numbering and coverage. Use the publisher’s official Latin-script bibliographic record where available; otherwise, use the transliteration system selected by the editorial team. Place the translated title in square brackets and identify the original language at the end of the entry. Retain the DOI.

No mandatory proportions are imposed for international sources, self-citations, or citations to the journal. Preprints and retracted articles must be clearly identified.

9. Revision and Publication Preparation

Revised submissions must include the amended manuscript and a point-by-point response to every comment, identifying changes or providing a reasoned explanation for disagreement. Authors are normally allowed 14 calendar days for minor revisions and 30 calendar days for major revisions, with extensions by agreement.

Proofs of accepted articles are sent to the corresponding author for approval in consultation with all co-authors. The usual response period is five working days.

A separate publishing agreement and consent to personal data processing are completed before publication. Detailed peer-review, payment, licensing, and appeals procedures are provided in the relevant sections of the website.